Apellis Pharmaceuticals Announces Formation of Scientific Advisory Board
July 16, 2015
Crestwood, KY – July 15, 2015 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the formation of a Scientific Advisory Board